Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Bile Duct Cancer”

298 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 298 results

Testing effectiveness (Phase 2)Looking for participantsNCT06728410
What this trial is testing

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Who this might be right for
Intrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation
Mehmet Akce 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Early research (Phase 1)Ended earlyNCT06420349
What this trial is testing

NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Advanced CholangiocarcinomaMetastatic CholangiocarcinomaRefractory Cholangiocarcinoma+4 more
Mayo Clinic 7
Testing effectiveness (Phase 2)UnknownNCT04454905
What this trial is testing

Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-sen University 50
Not applicableEnded earlyNCT03137706
What this trial is testing

Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer

Who this might be right for
Colon CarcinomaLiver and Intrahepatic Bile Duct CarcinomaPancreatic Carcinoma
University of Southern California 8
Not applicableStudy completedNCT03405909
What this trial is testing

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, IntrahepaticLiver Cirrhosis+3 more
University Hospital Erlangen 517
Testing effectiveness (Phase 2)UnknownNCT06375915
What this trial is testing

Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

Who this might be right for
Intrahepatic Cholangiocarcinoma
Francesco De Cobelli 33
Testing effectiveness (Phase 2)Study completedNCT00553332
What this trial is testing

Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer
National Cancer Institute (NCI) 29
Not applicableUnknownNCT02184871
What this trial is testing

Next Generation Sequencing in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University of Bologna 45
Testing effectiveness (Phase 2)WithdrawnNCT05019677
What this trial is testing

GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University
Testing effectiveness (Phase 2)Ended earlyNCT02878473
What this trial is testing

Liver Transplantation for Early Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
University Health Network, Toronto 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableUnknownNCT03990623
What this trial is testing

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Who this might be right for
Liver and Intrahepatic Bile Duct Carcinoma
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Looking for participantsNCT07570849
What this trial is testing

Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 35
Early research (Phase 1)Study completedNCT01825603
What this trial is testing

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Who this might be right for
Ampulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more
University of Nebraska 17
Not applicableEnrolling By InvitationNCT04195503
What this trial is testing

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
University Health Network, Toronto 10
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT05565794
What this trial is testing

Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements

Who this might be right for
Intrahepatic CholangiocarcinomaFGFR2 Gene MutationFGFR2 Gene Rearrangement+1 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 2
Large-scale testing (Phase 3)Ended earlyNCT02807181
What this trial is testing

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sirtex Medical 89
Not applicableUnknownNCT04410302
What this trial is testing

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Who this might be right for
Bladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct Carcinoma+2 more
University of California, Davis 500
Load More Results